KRH 2731

Drug Profile

KRH 2731

Alternative Names: KRH-2731-5HCl

Latest Information Update: 10 Dec 2007

Price : $50

At a glance

  • Originator Kureha Corporation
  • Class Antiretrovirals
  • Mechanism of Action CXCR4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 10 Aug 2004 Data presented at the 15th International AIDS Conference (IAC-2004) have been added to the pharmacokinetics and Viral Infections antimicrobial activity sections
  • 23 Feb 2004 Preclinical trials in HIV infections treatment in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top